Neogen Corporation Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-08-19: Form PRE 14A; Period of report 2021-10-07; Description PRE 14A; Document d147289dpre14a.htm.
- 2018-08-16: Form PRE 14A; Period of report 2018-10-04; Description PRE 14A; Document d607019dpre14a.htm.
- 2015-08-14: Form PRE 14A; Period of report 2015-10-01; Description PRELIMINARY PROXY STATEMENT; Document d93716dpre14a.htm.
- 2011-08-12: Form PRE 14A; Period of report 2011-10-06; Description PRELIMINARY PROXY STATEMENT; Document dpre14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2021-08-19 | PRE 14A | 2021-10-07 | PRE 14A | d147289dpre14a.htm |
| 2018-08-16 | PRE 14A | 2018-10-04 | PRE 14A | d607019dpre14a.htm |
| 2015-08-14 | PRE 14A | 2015-10-01 | PRELIMINARY PROXY STATEMENT | d93716dpre14a.htm |
| 2011-08-12 | PRE 14A | 2011-10-06 | PRELIMINARY PROXY STATEMENT | dpre14a.htm |
| 2007-08-24 | PRE 14A | 2007-10-11 | PRELIMINARY PROXY STATEMENT | dpre14a.htm |
| 1999-08-13 | PRE 14A | 1999-10-07 | Preliminary proxy statement |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |